Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

Nature Genetics volume 43, pages 699–705 (2011)Cite this article

Subjects

Abstract

Progressive supranuclear palsy (PSP) is a movement disorder with prominent tau neuropathology. Brain diseases with abnormal tau deposits are called tauopathies, the most common of which is Alzheimer's disease. Environmental causes of tauopathies include repetitive head trauma associated with some sports. To identify common genetic variation contributing to risk for tauopathies, we carried out a genome-wide association study of 1,114 individuals with PSP (cases) and 3,247 controls (stage 1) followed by a second stage in which we genotyped 1,051 cases and 3,560 controls for the stage 1 SNPs that yielded P ≤ 10−3. We found significant previously unidentified signals (P < 5 × 10−8) associated with PSP risk at STX6, EIF2AK3 and MOBP. We confirmed two independent variants in MAPT affecting risk for PSP, one of which influences MAPT brain expression. The genes implicated encode proteins for vesicle-membrane fusion at the Golgi-endosomal interface, for the endoplasmic reticulum unfolded protein response and for a myelin structural component.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Regional association plots.
Figure 2: Regional association results for the MAPT region of chromosome 17.
Figure 3: Effects of genotypes on gene expression for the MOBP region of chromosome 3 and for the MAPT region of chromosome 17.

Similar content being viewed by others

References

  1. Hoppitt, T. et al. A systematic review of the incidence and prevalence of long-term neurological conditions in the UK. Neuroepidemiology 36, 19–28 (2011).

    Article  Google Scholar 

  2. Litvan, I. Update on progressive supranuclear palsy. Curr. Neurol. Neurosci. Rep. 4, 296–302 (2004).

    Article  Google Scholar 

  3. Dickson, D.W., Rademakers, R. & Hutton, M.L. Progressive supranuclear palsy: pathology and genetics. Brain Pathol. 17, 74–82 (2007).

    Article  CAS  Google Scholar 

  4. Stamelou, M. et al. Rational therapeutic approaches to progressive supranuclear palsy. Brain 133, 1578–1590 (2010).

    Article  Google Scholar 

  5. McKee, A.C. et al. TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy. J. Neuropathol. Exp. Neurol. 69, 918–929 (2010).

    Article  CAS  Google Scholar 

  6. Golbe, L.I. et al. Follow-up study of risk factors in progressive supranuclear palsy. Neurology 47, 148–154 (1996).

    Article  CAS  Google Scholar 

  7. Stefansson, H. et al. A common inversion under selection in Europeans. Nat. Genet. 37, 129–137 (2005).

    Article  CAS  Google Scholar 

  8. Baker, M. et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum. Mol. Genet. 8, 711–715 (1999).

    Article  CAS  Google Scholar 

  9. Cruchaga, C. et al. 5′-upstream variants of CRHR1 and MAPT genes associated with age at onset in progressive supranuclear palsy and cortical basal degeneration. Neurobiol. Dis. 33, 164–170 (2009).

    Article  CAS  Google Scholar 

  10. Houlden, H. et al. Corticobasal degeneration and progressive supranuclear palsy share a common tau haplotype. Neurology 56, 1702–1706 (2001).

    Article  CAS  Google Scholar 

  11. Sundar, P.D. et al. Two sites in the MAPT region confer genetic risk for Guam ALS/PDC and dementia. Hum. Mol. Genet. 16, 295–306 (2007).

    Article  CAS  Google Scholar 

  12. Simon-Sanchez, J. et al. Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat. Genet. 41, 1308–1312 (2009).

    Article  CAS  Google Scholar 

  13. Chanock, S.J. et al. Replicating genotype-phenotype associations. Nature 447, 655–660 (2007).

    Article  CAS  Google Scholar 

  14. Skol, A.D., Scott, L.J., Abecasis, G.R. & Boehnke, M. Joint analysis is more efficient than replication-based analysis for two-stage genome-wide association studies. Nat. Genet. 38, 209–213 (2006).

    Article  CAS  Google Scholar 

  15. Zody, M.C. et al. Evolutionary toggling of the MAPT 17q21.31 inversion region. Nat. Genet. 40, 1076–1083 (2008).

    Article  CAS  Google Scholar 

  16. Tian, C. et al. Analysis and application of European genetic substructure using 300 K SNP information. PLoS Genet. 4, e4 (2008).

    Article  Google Scholar 

  17. Litvan, I. et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47, 1–9 (1996).

    Article  CAS  Google Scholar 

  18. Osaki, Y. et al. Accuracy of clinical diagnosis of progressive supranuclear palsy. Mov. Disord. 19, 181–189 (2004).

    Article  Google Scholar 

  19. Duffy, D.L. et al. Multiple pigmentation gene polymorphisms account for a substantial proportion of risk of cutaneous malignant melanoma. J. Invest. Dermatol. 130, 520–528 (2010).

    Article  CAS  Google Scholar 

  20. Farrer, L.A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. J. Am. Med. Assoc. 278, 1349–1356 (1997).

    Article  CAS  Google Scholar 

  21. Rademakers, R. et al. High-density SNP haplotyping suggests altered regulation of tau gene expression in progressive supranuclear palsy. Hum. Mol. Genet. 14, 3281–3292 (2005).

    Article  CAS  Google Scholar 

  22. Caffrey, T.M., Joachim, C., Paracchini, S., Esiri, M.M. & Wade-Martins, R. Haplotype-specific expression of exon 10 at the human MAPT locus. Hum. Mol. Genet. 15, 3529–3537 (2006).

    Article  CAS  Google Scholar 

  23. Myers, A.J. et al. The MAPT H1c risk haplotype is associated with increased expression of tau and especially of 4 repeat containing transcripts. Neurobiol. Dis. 25, 561–570 (2007).

    Article  CAS  Google Scholar 

  24. Harold, D. et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat. Genet. 41, 1088–1093 (2009).

    Article  CAS  Google Scholar 

  25. Lambert, J.C. et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat. Genet. 41, 1094–1099 (2009).

    Article  CAS  Google Scholar 

  26. Seshadri, S. et al. Genome-wide analysis of genetic loci associated with Alzheimer disease. J. Am. Med. Assoc. 303, 1832–1840 (2010).

    Article  CAS  Google Scholar 

  27. Naj, A.C. et al. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat. Genet. 43, 436–441 (2011).

    Article  CAS  Google Scholar 

  28. Hollingworth, P. et al. Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat. Genet. 43, 429–435 (2011).

    Article  CAS  Google Scholar 

  29. Nalls, M.A. et al. Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies. Lancet 377, 641–649 (2011).

    Article  Google Scholar 

  30. Unterberger, U. et al. Endoplasmic reticulum stress features are prominent in Alzheimer disease but not in prion diseases in vivo. J. Neuropathol. Exp. Neurol. 65, 348–357 (2006).

    Article  CAS  Google Scholar 

  31. Hoozemans, J.J.M. et al. The unfolded protein response is activated in pretangle neurons in Alzheimer's disease hippocampus. Am. J. Pathol. 174, 1241–1251 (2009).

    Article  CAS  Google Scholar 

  32. Hoozemans, J.J. et al. Activation of the unfolded protein response in Parkinson's disease. Biochem. Biophys. Res. Commun. 354, 707–711 (2007).

    Article  CAS  Google Scholar 

  33. Jahn, R. & Scheller, R.H. SNAREs–engines for membrane fusion. Nat. Rev. Mol. Cell Biol. 7, 631–643 (2006).

    Article  CAS  Google Scholar 

  34. Wendler, F. & Tooze, S. Syntaxin 6: the promiscuous behaviour of a SNARE protein. Traffic 2, 606–611 (2001).

    Article  CAS  Google Scholar 

  35. Montague, P., McCallion, A.S., Davies, R.W. & Griffiths, I.R. Myelin-associated oligodendrocytic basic protein: a family of abundant CNS myelin proteins in search of a function. Dev. Neurosci. 28, 479–487 (2006).

    Article  CAS  Google Scholar 

  36. Scheper, W. & Hoozemans, J.J.M. Endoplasmic reticulum protein quality control in neurodegenerative disease: the good, the bad and the therapy. Curr. Med. Chem. 16, 615–626 (2009).

    Article  CAS  Google Scholar 

  37. Paschen, W. & Mengesdorf, T. Cellular abnormalities linked to endoplasmic reticulum dysfunction in cerebrovascular disease—therapeutic potential. Pharmacol. Ther. 108, 362–375 (2005).

    Article  CAS  Google Scholar 

  38. Hauw, J.J. et al. Preliminary NINDS neuropathologic criteria for Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy). Neurology 44, 2015–2019 (1994).

    Article  CAS  Google Scholar 

  39. Dickson, D.W. et al. Office of rare diseases neuropathologic criteria for corticobasal degeneration. J. Neuropathol. Exp. Neurol. 61, 935–946 (2002).

    Article  CAS  Google Scholar 

  40. Lee, A.B., Luca, D., Klei, L., Devlin, B. & Roeder, K. Discovering genetic ancestry using spectral graph theory. Genet. Epidemiol. 34, 51–59 (2010).

    Article  CAS  Google Scholar 

  41. Crossett, A. et al. Using ancestry matching to combine family-based and unrelated samples for genome-wide association studies. Stat. Med. 29, 2932–2945 (2010).

    Article  Google Scholar 

  42. Tian, C., Plenge, R.M., Ransom, M., Lee, A. & Villoslada, P. Analysis and application of European genetic substructure using 300K SNP information. PLoS Genet. 4, e4 (2008).

    Article  Google Scholar 

  43. Price, A.L. et al. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38, 904–909 (2006).

    Article  CAS  Google Scholar 

  44. Luca, D. et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am. J. Hum. Genet. 82, 453–463 (2008).

    Article  CAS  Google Scholar 

  45. Wu, J., Devlin, B., Ringquist, S., Trucco, M. & Roeder, K. Screen and clean: a tool for identifying interactions in genome-wide association studies. Genet Epidemiol 34, 275–285 (2010).

    PubMed  PubMed Central  Google Scholar 

  46. Gibbs, J.R. et al. Abundant quantitative trait loci exist for DNA methylation and gene expression in human brain. PLoS Genet. 6, e1000952 (2010).

    Article  Google Scholar 

  47. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analysis. Am. J. Hum. Genet. 81, 559–575 (2007).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank the subjects and their families that participated in this study. This work was funded by grants from the CurePSP Foundation, the Peebler PSP Research Foundation and US National Institutes of Health (NIH) grants R37 AG 11762, R01 PAS-03-092, P50 NS72187, P01 AG17216 (National Institute on Aging (NIA)/NIH), MH057881 and MH077930 (National Institute of Mental Health (NIMH)). Work was also supported in part by the NIA Intramural Research Program, the German National Genome Research Network (01GS08136-4) and the Deutsche Forschungsgemeinschaft (HO 2402/6-1), Prinses Beatrix Fonds (JCvS, 01-0128), the Reta Lila Weston Trust and the UK Medical Research Council (RdS: G0501560). The Newcastle Brain Tissue Resource provided tissue and is funded in part by a grant from the UK Medical Research Council (G0400074), by the Newcastle National Institute for Health Research (NIHR) Biomedical Research Centre in Ageing and Age Related Diseases to the Newcastle upon Tyne Hospitals National Health Service Foundation Trust and by a grant from the Alzheimer's Society and Alzheimer's Research Trust as part of the Brains for Dementia Research Project. We acknowledge the contribution of many tissue samples from the Harvard Brain Tissue Resource Center. We also acknowledge the 'Human Genetic Bank of Patients affected by Parkinson Disease and Parkinsonism' (http://www.parkinson.it/dnabank.html) of the Telethon Genetic Biobank Network, supported by TELETHON Italy (project no. GTB07001) and by Fondazione Grigioni per il Morbo di Parkinson. The University of Toronto sample collection was supported by grants from Wellcome Trust, Howard Hughes Medical Institute and the Canadian Institute of Health Research. Brain-Net-Germany is supported by the Federal Ministry of Education and Research (BMBF) (01GI0505). R.d.S., A.J.L. and J.A.H. are funded by the Reta Lila Weston Trust and the PSP (Europe) Association. R.d.S. is funded by the UK Medical Research Council (Grant G0501560) and Cure PSP+. Z.K.W. is partially supported by the NIH/NINDS 1RC2NS070276, NS057567, P50NS072187, Mayo Clinic Florida (MCF) Research Committee CR programs (MCF #90052030 and MCF #90052030) and the gift from C.E. Bolch Jr. and S.B. Bolch (MCF #90052031/PAU #90052). The Mayo Clinic College of Medicine would like to acknowledge M. Baker, R. Crook, M. DeJesus-Hernandez and N. Rutherford for their preparation of samples. P.P. was supported by a grant from the Government of Navarra ('Ayudas para la Realización de Proyectos de Investigación' 2006–2007) and acknowledges the 'Iberian Atypical Parkinsonism Study Group Researchers': M.A. Pastor, M.R. Luquin, M. Riverol, J.A. Obeso and M.C. Rodriguez-Oroz (Department of Neurology, Clínica Universitaria de Navarra, University of Navarra, Pamplona, Spain), M. Blazquez (Neurology Department, Hospital Universitario Central de Asturias, Oviedo, Spain), A. Lopez de Munain, B. Indakoetxea, J. Olaskoaga, J. Ruiz, J. Félix Martí Massó (Servicio de Neurología, Hospital Donostia, San Sebastián, Spain), V. Alvarez (Genetics Department, Hospital Universitario Central de Asturias, Oviedo, Spain), T. Tuñon (Banco de Tejidos Neurologicos, CIBERNED, Hospital de Navarra, Navarra, Spain), F. Moreno (Servicio de Neurología, Hospital Ntra. Sra. de la Antigua, Zumarraga, Gipuzkoa, Spain), A. Alzualde (Neurogenétics Department, Hospital Donostia, San Sebastián, Spain). E.T. wishes to acknowledge the Banco de Tejidos Neurológicos de la Universidad de Barcelona-Hospital Clinic, which provided many tissue samples for the project. We also acknowledge E. Loomis for providing technical support.

The datasets used for older controls were obtained from Database for Genotypes and Phenotypes (dbGap) at http://www.ncbi.nlm.nih.gov/gap/. Funding support for the 'Genetic Consortium for Late Onset Alzheimer's Disease' was provided through the Division of Neuroscience, NIA. The Genetic Consortium for Late Onset Alzheimer's Disease (study accession number: phs000168.v1.p1.) includes a genome-wide association study funded as part of the Division of Neuroscience, NIA. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Genetic Consortium for Late Onset Alzheimer's Disease. Funding support for the 'CIDR Visceral Adiposity Study' (study accession number: phs000169.v1.p1.) was provided through the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA. The CIDR Visceral Adiposity Study includes a genome-wide association study funded as part of the Division of Aging Biology and the Division of Geriatrics and Clinical Gerontology, NIA. Assistance with phenotype harmonization and genotype cleaning, as well as with general study coordination, was provided by Heath ABC Study Investigators. Funding support for the Personalized Medicine Research Project (PMRP) was provided through a cooperative agreement (U01HG004608) with the National Human Genome Research Institute (NHGRI), with additional funding from the National Institute for General Medical Sciences (NIGMS). The samples used for PMRP analyses were obtained with funding from Marshfield Clinic, Health Resources Service Administration Office of Rural Health Policy grant number D1A RH00025 and Wisconsin Department of Commerce Technology Development Fund contract number TDF FYO10718. Funding support for genotyping, which was performed at Johns Hopkins University, was provided by the NIH (U01HG004438). Assistance with phenotype harmonization and genotype cleaning was provided by the eMERGE Administrative Coordinating Center (U01HG004603) and the National Center for Biotechnology Information (NCBI). The datasets used for the analyses described in this manuscript were obtained from dbGaP at http://www.ncbi.nlm.nih.gov/gap through dbGaP accession number phs000170.v1.p1.

Author information

Author notes

  1. Günter U Höglinger, Nadine M Melhem, Dennis W Dickson, Patrick M A Sleiman, Pia Winter, Ulrich Müller and Gerard D Schellenberg: These authors contributed equally to this work.

Authors and Affiliations

  1. Department of Neurology, Philipps-Universität, Marburg, Germany

    Günter U Höglinger

  2. Department of Psychiatry, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

    Nadine M Melhem, Lambertus Klei & Bernie Devlin

  3. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA

    Dennis W Dickson & Rosa Rademakers

  4. Center for Applied Genomics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

    Patrick M A Sleiman & Hakon Hakonarson

  5. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Li-San Wang, Laura B Cantwell, Mi Ryung Han & Gerard D Schellenberg

  6. Reta Lila Weston Institute, University College London (UCL) Institute of Neurology, London, UK

    Rohan de Silva, Jana Vandrovcova, J Raphael Gibbs, Dena G Hernandez, John Hardy & Andrew J Lees

  7. Department of Neurology, Division of Movement Disorders, University of Louisville, Louisville, Kentucky, USA

    Irene Litvan

  8. Department of Neurology, University Hospitals, Case Western Reserve University, Cleveland, Ohio, USA

    David E Riley

  9. Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands

    John C van Swieten

  10. Department of Clinical Genetics, Vrije Universiteit (VU) Medical Center, Section Medical Genomics, Amsterdam, The Netherlands

    Peter Heutink

  11. Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA

    Zbigniew K Wszolek & Ryan J Uitti

  12. Department of Neurology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA

    Howard I Hurtig & Rachel G Gross

  13. Department of Neurodegeneration, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany

    Walter Maetzler

  14. German Center for Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany

    Walter Maetzler

  15. Parkinson Institute, Istituti Clinici di Perfezionamento, Milano, Italy

    Stefano Goldwurm

  16. Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain

    Eduardo Tolosa

  17. Department of Medical and Surgical Sciences, Institute of Neurology, University of Brescia, Brescia, Italy

    Barbara Borroni

  18. CIBERNED, Instituto de Salud Carlos III, Madrid, Spain

    Pau Pastor

  19. Division of Neurosciences, Neurogenetics laboratory, University of Navarra Center for Applied Medical Research, Pamplona, Spain

    Pau Pastor

  20. Department of Neurology, University of Navarra, Clínica Universidad de Navarra, Pamplona, Spain

    Pau Pastor

  21. Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA

    Allissa Dillman, J Raphael Gibbs, Mark R Cookson, Dena G Hernandez & Andrew B Singleton

  22. Department of Neuroscience, The Scripps Research Institute, Jupiter, Florida, USA

    Marcel P van der Brug

  23. Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

    Matthew J Farrer

  24. Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA

    Chang-En Yu

  25. Geriatric Research, Education, and Clinical Center (GRECC), Veterans Affairs Puget Sound Health Care System, Seattle, Washington, USA

    Chang-En Yu

  26. Department of Neurology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, USA

    Lawrence I Golbe

  27. Department of Molecular Neuroscience, Queen Square Brain Bank for Neurological Disorders, UCL Institute of Neurology, University College London, London, UK

    Tamas Revesz & Andrew J Lees

  28. Institut for Humangenetik, Justus-Liebig-Universität, Giessen, Germany

    Ulrich Müller

  29. Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA

    Roger L Albin

  30. Geriatrics Research, Education, and Clinical Center, Veterans Affairs (VA) Ann Arbor Health System, Ann Arbor, Michigan, USA

    Roger L Albin

  31. CIBERNED, Instituto de Salud Carlos III, Madrid, Spain

    Elena Alonso

  32. Division of Neurosciences, Neurogenetics Laboratory, University of Navarra Center for Applied Medical Research, Pamplona, Spain

    Elena Alonso

  33. Parkinson Institute, Istituti Clinici di Perfezionamento, Milan, Italy

    Angelo Antonini, Margherita Canesi, Roberto Cilia, Claudio Mariani, Nicoletta Meucci, Gianni Pezzoli, Giorgio Sacilotto, Silvana Tesei & Anna L Zecchinelli

  34. Department for Parkinson's Disease, Istituto Di Ricovero e Cura a Carattere Scientifico (IRCCS) San Camillo, Venice, Italy

    Angelo Antonini

  35. Institute of Legal Medicine, University of Würzburg, Würzburg, Germany

    Manuela Apfelbacher

  36. Department of Psychiatry, Center for Neurobiology and Behavior, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Steven E Arnold

  37. Centro de Biologia Molecular Severo Ochoa (CSIC-UAM), Campus Cantoblanco, Universidad Autonoma de Madrid, Madrid, Spain

    Jesus Avila

  38. Civin Laboratory for Neuropathology, Banner Sun Health Research Institute, Sun City, Arizona, USA

    Thomas G Beach

  39. Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA

    Sherry Beecher, Evan T Geller, Virginia M Lee, John Q Trojanowski & Vivianna M Van Deerlin

  40. Department of Neurodegeneration, Center of Neurology, Hertie Institute for Clinical Brain Research, University of Tübingen and German Center for Neurodegenerative diseases (DZNE), Tübingen, Germany

    Daniela Berg, Thomas Gasser & Karin Srulijes

  41. Geriatrics Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA

    Thomas D Bird

  42. Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Hudding University Hospital, Stockholm, Sweden

    Nenad Bogdanovic

  43. Department of Neurology, Erasmus University Medical Center, Rotterdam, The Netherlands

    Agnita J W Boon, Wang Zheng Chiu & Laura Donker Kaat

  44. Department of Neurology, University of California Los Angeles, Los Angeles, California, USA

    Yvette Bordelon

  45. Centre de Recherche de l'Institut du Cerveau et de la Moelle épinière, Université Pierre et Marie Curie, Paris, France

    Alexis Brice, Alexandra Durr & Isabelle Leber

  46. Institut National de la Santé et de la Recherche Médicale, Paris, France

    Alexis Brice, Alexandra Durr & Isabelle Leber

  47. Centre National de la Recherche Scientifique, Paris, France

    Alexis Brice, Alexandra Durr & Isabelle Leber

  48. Institute of Neurology, Medical University Vienna, Vienna, Austria

    Herbert Budka

  49. Dipartimento di Scienze Neurologiche e Psichiatriche, Sapienza Università di Roma, Rome, Italy

    Carlo Colosimo, Giovanni Fabbrini & Donatella Ottaviani

  50. Department of Biomedical Sciences, University of Antwerp, Antwerp, Belgium

    Peter P De Deyn & Sebastiaan Engelborghs

  51. Department of Neurology, Hospital Ramón y Cajal, Madrid, Spain

    Justo García de Yebenes

  52. Wien Center for Alzheimer's Disease and Memory Disorders, Mt. Sinai Medical Center, Miami Beach, Florida, USA

    Ranjan Duara

  53. Department of Neuroscience, Mayo Clinic, Jacksonville, Florida, USA

    NiCole A Finch & Owen A Ross

  54. Centre for Neuroscience, Flinders University and Australian Brain Bank Network, Victoria, Australia

    Robyn Flook

  55. C.S. Kubik Laboratory for Neuropathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

    Matthew P Frosch

  56. Neurology Service, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain

    Carles Gaig

  57. Department of Neurosciences, University of California San Diego, La Jolla, California, USA

    Douglas R Galasko & Eliezer Masliah

  58. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, Georgia, USA

    Marla Gearing

  59. Department of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA

    Bernardino Ghetti & Salvatore Spina

  60. Department of Neurology, Mayo Clinic, Jacksonville, Florida, USA

    Neill R Graff-Radford

  61. Department of Neurology, University of Pennsylvania Health System, Philadelphia, Pennsylvania, USA

    Murray Grossman

  62. Department of Neurological Sciences, Rush University, Chicago, Illinois, USA

    Deborah A Hall

  63. Tanz Centre for Research in Neurodegenerative Disease, University of Toronto, Toronto, Ontario, Canada

    Lili-Naz Hazrati & Peter St. George-Hyslop

  64. Department of Neurology, Philipps University, Marburg, Germany

    Matthias Höllerhage, Jens C Möller, Wolfgang H Oertel, Gesine Respondek & Maria Stamelou

  65. Department of Neurology, Baylor College of Medicine, Houston, Texas, USA

    Joseph Jankovic

  66. Department of Neurology, Emory University, Atlanta, Georgia, USA

    Jorge L Juncos

  67. Department of Neurology, Memory and Aging Center, University of California, San Francisco, San Francisco, California, USA

    Anna Karydas, Bruce L Miller & William W Seeley

  68. Institut für Neuropathologie, Ludwig-Maximilians-Universität and Brain Net Germany, Munich, Germany

    Hans A Kretzschmar & Sigrun Roeber

  69. Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, USA

    Andrew P Lieberman

  70. Department of Neurology, University of Kansas Medical Center, Kansas City, Kansas, USA

    Kelly E Lyons & Rajesh Pahwa

  71. Department of Pathology, University of California San Diego, La Jolla, California, USA

    Eliezer Masliah

  72. Reta Lila Weston Institute, UCL Institute of Neurology, University College London, London, UK

    Luke A Massey, Sean S O'Sullivan & Laura Silveira-Moriyama

  73. Victorian Brain Bank Network, Mental Health Research Institute, Victoria, Australia

    Catriona A McLean

  74. Department of Neurology, Georg-August University, Goettingen, Germany

    Brit Mollenhauer

  75. Paracelsus-Elena-Klinik, University of Goettingen, Kassel, Germany

    Brit Mollenhauer & Claudia Trenkwalder

  76. Medical Research Council (MRC) Centre for Neuropsychiatric Genetics and Department of Neurology, School of Medicine, Cardiff University, Cardiff, UK

    Huw R Morris

  77. Newcastle Brain Tissue Resource, Newcastle University, Institute for Ageing and Health, Newcastle upon Tyne, UK

    Chris Morris

  78. Department of Medical and Surgical Sciences, Institute of Neurology, University of Brescia, Brescia, Italy

    Alessandro Padovani

  79. Neurodegeneration and Mental Health Research Group, Faculty of Human and Medical Sciences, University of Manchester, Manchester, UK

    Stuart Pickering-Brown

  80. Department of Neurology, Innsbruck Medical University, Innsbruck, Austria

    Werner Poewe, Klaus Seppi & Gregor K Wenning

  81. Department of Neuropathology and Tissue Bank, Fundación Centro Investigación Enfermedades Neurológicas (CIEN), Instituto de Salud Carlos III, Madrid, Spain

    Alberto Rabano

  82. Division of Neurology, Royal University Hospital, University of Saskatchewan, Saskatchewan, Canada

    Alex Rajput

  83. Department of Neurology, University of Maryland School of Medicine, Baltimore, Maryland, USA

    Stephen G Reich

  84. Department of Neurodegenerative Disease, Dementia Research Centre, UCL Institute of Neurology, UCL, London, UK

    Jonathan D Rohrer & Martin N Rossor

  85. Cambridge Institute for Medical Research and Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK

    Peter St. George-Hyslop

  86. Department of Neurology, Center for Neurodegeneration and Experimental Therapeutics, University of Alabama at Birmingham, Birmingham, Alabama, USA

    David G Standaert

  87. Human Brain and Spinal Fluid Resource Center, Veterans Affairs West Los Angeles Healthcare Center, Los Angeles, California, USA

    Wallace W Tourtellotte

  88. Department of Clinical Neuroscience, MRC Centre for Neurodegeneration Research, King's College London, London, UK

    Claire Troakes

  89. Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

    Juan C Troncoso

  90. Department of Pathology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, New York, New York, USA

    Jean Paul G Vonsattel

  91. Department of Pathology, University of Texas Southwestern Medical Center, Dallas, Texas, USA

    Charles L White

  92. Institute of Human Genetics, Justus-Liebig University, Giessen, Germany

    Pia Winter

  93. Rancho Los Amigos National Rehabilitation Center, University of Southern California, Downey, California, USA

    Chris Zarow

Authors
  1. Günter U Höglinger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nadine M Melhem
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Dennis W Dickson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Patrick M A Sleiman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Li-San Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lambertus Klei
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Rosa Rademakers
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Rohan de Silva
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Irene Litvan
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. David E Riley
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. John C van Swieten
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Peter Heutink
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Zbigniew K Wszolek
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Ryan J Uitti
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Jana Vandrovcova
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Howard I Hurtig
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Rachel G Gross
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Walter Maetzler
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Stefano Goldwurm
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Eduardo Tolosa
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Barbara Borroni
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Pau Pastor
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Laura B Cantwell
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Mi Ryung Han
    View author publications

    You can also search for this author in PubMed Google Scholar

  25. Allissa Dillman
    View author publications

    You can also search for this author in PubMed Google Scholar

  26. Marcel P van der Brug
    View author publications

    You can also search for this author in PubMed Google Scholar

  27. J Raphael Gibbs
    View author publications

    You can also search for this author in PubMed Google Scholar

  28. Mark R Cookson
    View author publications

    You can also search for this author in PubMed Google Scholar

  29. Dena G Hernandez
    View author publications

    You can also search for this author in PubMed Google Scholar

  30. Andrew B Singleton
    View author publications

    You can also search for this author in PubMed Google Scholar

  31. Matthew J Farrer
    View author publications

    You can also search for this author in PubMed Google Scholar

  32. Chang-En Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  33. Lawrence I Golbe
    View author publications

    You can also search for this author in PubMed Google Scholar

  34. Tamas Revesz
    View author publications

    You can also search for this author in PubMed Google Scholar

  35. John Hardy
    View author publications

    You can also search for this author in PubMed Google Scholar

  36. Andrew J Lees
    View author publications

    You can also search for this author in PubMed Google Scholar

  37. Bernie Devlin
    View author publications

    You can also search for this author in PubMed Google Scholar

  38. Hakon Hakonarson
    View author publications

    You can also search for this author in PubMed Google Scholar

  39. Ulrich Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  40. Gerard D Schellenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

PSP Genetics Study Group

  • Roger L Albin
  • , Elena Alonso
  • , Angelo Antonini
  • , Manuela Apfelbacher
  • , Steven E Arnold
  • , Jesus Avila
  • , Thomas G Beach
  • , Sherry Beecher
  • , Daniela Berg
  • , Thomas D Bird
  • , Nenad Bogdanovic
  • , Agnita J W Boon
  • , Yvette Bordelon
  • , Alexis Brice
  • , Herbert Budka
  • , Margherita Canesi
  • , Wang Zheng Chiu
  • , Roberto Cilia
  • , Carlo Colosimo
  • , Peter P De Deyn
  • , Justo García de Yebenes
  • , Laura Donker Kaat
  • , Ranjan Duara
  • , Alexandra Durr
  • , Sebastiaan Engelborghs
  • , Giovanni Fabbrini
  • , NiCole A Finch
  • , Robyn Flook
  • , Matthew P Frosch
  • , Carles Gaig
  • , Douglas R Galasko
  • , Thomas Gasser
  • , Marla Gearing
  • , Evan T Geller
  • , Bernardino Ghetti
  • , Neill R Graff-Radford
  • , Murray Grossman
  • , Deborah A Hall
  • , Lili-Naz Hazrati
  • , Matthias Höllerhage
  • , Joseph Jankovic
  • , Jorge L Juncos
  • , Anna Karydas
  • , Hans A Kretzschmar
  • , Isabelle Leber
  • , Virginia M Lee
  • , Andrew P Lieberman
  • , Kelly E Lyons
  • , Claudio Mariani
  • , Eliezer Masliah
  • , Luke A Massey
  • , Catriona A McLean
  • , Nicoletta Meucci
  • , Bruce L Miller
  • , Brit Mollenhauer
  • , Jens C Möller
  • , Huw R Morris
  • , Chris Morris
  • , Sean S O'Sullivan
  • , Wolfgang H Oertel
  • , Donatella Ottaviani
  • , Alessandro Padovani
  • , Rajesh Pahwa
  • , Gianni Pezzoli
  • , Stuart Pickering-Brown
  • , Werner Poewe
  • , Alberto Rabano
  • , Alex Rajput
  • , Stephen G Reich
  • , Gesine Respondek
  • , Sigrun Roeber
  • , Jonathan D Rohrer
  • , Owen A Ross
  • , Martin N Rossor
  • , Giorgio Sacilotto
  • , William W Seeley
  • , Klaus Seppi
  • , Laura Silveira-Moriyama
  • , Salvatore Spina
  • , Karin Srulijes
  • , Peter St. George-Hyslop
  • , Maria Stamelou
  • , David G Standaert
  • , Silvana Tesei
  • , Wallace W Tourtellotte
  • , Claudia Trenkwalder
  • , Claire Troakes
  • , John Q Trojanowski
  • , Juan C Troncoso
  • , Vivianna M Van Deerlin
  • , Jean Paul G Vonsattel
  • , Gregor K Wenning
  • , Charles L White
  • , Pia Winter
  • , Chris Zarow
  •  & Anna L Zecchinelli

Contributions

Co-first authors G.U.H., N.M.M., D.W.D. and P.M.A.S. and senior authors U.M. and G.D.S. contributed equally to this project. G.U.H. and U.M. initiated this study and consortium, drafted the first grant and protocol, coordinated the European sample acquisition and preparation, contributed to data interpretation and contributed to the preparation of the manuscript. N.M.M. conducted the analyses and contributed to the preparation of the manuscript. D.W.D. contributed to study design, data interpretation and preparation of the manuscript. P.M.A.S. contributed in the selection of controls for both phases of the experiment, data quality control, data analysis and content curation for the replication phase custom array. L.-S.W. participated in the initial association analysis, eSNP and pathway analysis and functional annotation of SNPs in the top genes. L.K. participated in genotype quality control and analysis. R.R. and R.d.S. participated in study design, sample preparation and revising the manuscript for content. I. Litvan, D.E.R., J.C.V.S., P.H., Z.K.W., R.J.U., J.V., H.I.H., R.G.G., W.M., S.G., E.T., B.B., P.P. and the PSP Genetics Study Group (R.L.A., E.A., A.A., M.A., S.E.A., J.A., T.B., S.B., D.B., T.D.B., N.B., A.J.W.B., Y.B., A.B., H.B., M.C., W.Z.C., R.C., C.C., P.P.D., J.G.D., L.D.K., R.D., A. Durr, S.E., G.F., N.A.F., R.F., M.P.F., C.G., D.R.G., T.G., M. Gearing, E.T.G., B.G., N.R.G.R., M. Grossman, D.A.H., L.H., M.H., J.J., J.L.J., A.K., H.A.K., I. Leber, V.M.L., A.P.L., K.L., C. Mariani, E.M., L.A.M., C.A.M., N.M., B.L.M., B.M., J.C.M., H.R.M., C. Morris, S.S.O., W.H.O., D.O., A.P., R.P., G.P., S.P.B., W.P., A. Rabano, A. Rajput, S.G.R., G.R., S.R., J.D.R., O.A.R., M.N.R., G.S., W.W.S., K. Seppi, L.S.M., S.S., K. Srulijes, P.S.G., M.S., D.G.S., S.T., W.W.T., C. Trenkwalder, C. Troakes, J.Q.T., J.C.T., V.M.V., J.P.G.V., G.K.W., C.L.W., P.W., C.Z. and A.L.Z.) participated in characterization, preparation and contribution of samples from individuals with PSP. L.B.C. coordinated the project, sample acquisition and selection and managed phenotypes. M.R.H. conducted eSNP and pathway analysis. A. Dillman performed mRNA expression experiments in human brain. M.P.v.d.B. and D.G.H. performed mRNA expression experiments in human brain and contributed to the design of eQTL experiments. J.R.G. performed computational and statistical analysis of the eQTL data and contributed to the design of eQTL experiments. M.R.C. and A.B.S. were responsible for overall supervision, design and analysis of eQTL experiments. J.C.V.S., M.J.F., L.I.G., J.H. and A.J.L. participated in study design and data analysis discussions. C.-E.Y. and T.R. participated in the initial design of experiments. B.D. supervised analyses and contributed to the writing of the manuscript. H.H. supervised genotyping and platform and sample selection, participated in analyses and reviewed the manuscript. G.D.S. led the consortium, supervised study design, coordinated the US sample acquisition and preparation, contributed to data interpretation and wrote and coordinated assembly of the manuscript.

Corresponding authors

Correspondence to Ulrich Müller or Gerard D Schellenberg.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Additional information

A list of members appears at the end of the paper.

Supplementary information

Supplementary Text and Figures

Supplementary Tables 1–6 and 8–10 and Supplementary Figures 1–5. (PDF 701 kb)

Supplementary Table 7

Location and functional consequence of SNPs in genes from the PSP GWAS signals (XLS 54 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Höglinger, G., Melhem, N., Dickson, D. et al. Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy. Nat Genet 43, 699–705 (2011). https://doi.org/10.1038/ng.859

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.859

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing